Rgenix is a privately-held clinical-stage biopharmaceutical company developing first-in-class drugs that target key pathways in cancer progression.

310 E 67th St, Suite 1-12‎, New York, NY 10065
(646) 856-9261
[email protected]

Board of Directors

Dieter Weinand

Dieter is Chairman of the Board of Inspirna.

Masoud Tavazoie, M.D., Ph.D.

Masoud is Chief Executive Officer and co-founder of Inspirna.

Eric Rowinsky, M.D.

Eric is the Chief Medical Officer of Hummingbird Bioscience.

Jack Nielsen

Jack B. Nielsen is a Partner of Vivo Capital.

Michael Ginder

Michael is currently a research analyst at Sands Capital, a leading growth-oriented investment firm.

Antoine Papiernik

Antoine Papiernik is a Managing Partner at Sofinnova Partners, which he joined in 1997.

Raymond Camahort, Ph.D.

Ray is a Partner at Novo Ventures.

Peter Van Vlasselaer, Ph.D.

Peter is a Venture Partner at SR One.

Jue Pu

Jue leads the cancer biomarker and liquid biopsy research and development at Lepu Medical.